Expression of CCN3 protein in human Wilms' tumors: Immunohistochemical detection of CCN3 variants using domain-specific antibodies

Virchows Archiv

Volumn 452, Issue 1, 2008, Pages 33-39

  Subramaniam, Manish Mani ^a   Lazar, Noureddine ^b   Navarro, Samuel ^a   Perbal, Bernard ^b   Llombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CCN3; Domain specific antibodies; Nov; Truncated protein; Wilms' tumors

Indexed keywords

CCN3 PROTEIN; CYTOPLASM PROTEIN; FORMALDEHYDE; PARAFFIN; PROTEIN ANTIBODY; PROTEIN DERIVATIVE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ARTICLE; BLASTEMA; CARBOXY TERMINAL SEQUENCE; CARCINOGENIC ACTIVITY; CLINICAL ARTICLE; CYTOPLASM; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY TUBULE; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN VARIANT; TUMOR CELL;

ANTIBODIES, MONOCLONAL; CELL NUCLEUS; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS); WILMS TUMOR;

EID: 37549005229     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0523-3     Document Type: Article

References (30)

1. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P, Scotlandi K (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24:4349-4361
2. Bork P (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327:125-130
3. Breslow N, Beckwith JB, Ciol M, Sharples K (1988) Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study. Cancer Res 48:1653-1657
4. Brigstock DR, Goldschmeding R, Katsube KI, Lam SC, Lau LF, Lyons K, Naus C, Perbal B, Riser B, Takigawa M, Yeger H (2003) Proposal for a unified CCN nomenclature. Mol Pathol 56:127-128
5. Cervello M, Giannitrapani L, Labbozzetta M, Notarbartolo M, D'Alessandro N, Lampiasi N, Azzolina A, Montalto G (2004) Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. Ann N Y Acad Sci 1028:432-439
6. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B (1998) novH: differential expression in developing kidney and Wilms' tumors. Am J Pathol 152:1563-1575
7. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2002) Pathology and genetics of tumors of the urinary system and male genital organs. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of tumors. IARC Press, Lyon
8. Ellis PD, Metcalfe JC, Hyvonen M, Kemp PR (2003) Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5beta1. J Vasc Res 40:234-243
9. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E (2004) Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279:36931-36942
10. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR (2001) Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54:293-299
11. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE (2004) Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11:781-791
12. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12:10-21
13. Kyurkchiev S, Yeger H, Bleau AM, Perbal B (2004) Potential cellular conformations of the CCN3 (NOV) protein. Cell Commun Signal 2:9-17
14. Leu SJ, Liu Y, Chen N, Chen CC, Lam SC, Lau LF (2003) Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61). J Biol Chem 278:33801-33808
15. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY, Lau LF (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278:24200-24208
16. Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM, Lau LF (2005) Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem 280:8229-8237
17. Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K (2002) The expression of ccn3 (nov) gene in musculoskeletal tumors. Am J Pathol 160:849-859
18. McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD, Irvine AE (2006) A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 108:1716-1723
19. Olsnes S, Klingenberg O, Wiedlocha A (2003) Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol Rev 83:163-182
20. Perbal B (1999) Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression. Mol Pathol 52:84-91
21. Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54:57-79
22. Perbal B (2004) CCN proteins: multifunctional signalling regulators. Lancet 363:62-64
23. Perbal B (2006) The CCN3 protein and cancer. Adv Exp Med Biol 587:23-40
24. Planque N, Bleau AM, Perbal B (2005) The CCN3 protein: a multifunctional cell growth regulator. In: Perbal B, Takigawa M (eds) The CCN proteins: a new family of cell growth and differentiation regulators. Imperial College Press, London, pp 239-257
25. Planque N, Perbal B (2003) A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int 3:1-15
26. Planque N, Perbal B (2003) The CCN Proteins, a new family of cell growth regulators. In: Pandalai SG (ed) Recent research developments in human pathology, vol 1. 2003 Part II. Transworld Research Network, Trivandrum, pp 333-369
27. Planque N, Long Li C, Saule S, Bleau AM, Perbal B (2006) Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J Cell Biochem 99:105-116
28. Wahab NA, Brinkman H, Mason RM (2001) Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359:77-87
29. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP (2004) Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10:2072-2081
30. Yeger H, Chevalier G, Alami J, Perbal B (1998) Expression of novH in rhabdomyosarcoma. Proc Am Assoc Cancer Res 39 (Abstract 265)